领航细胞病理新赛道 打造肿瘤早筛"中国芯"——言鼎生物医疗团队斩获青岛产业领军殊荣

Group 1 - The 2025 Qingdao Science and Technology Activity Week was officially launched with the theme "Innovation-Driven Development, Technology Leading the Future" [1] - The project team led by Professor Xiao Leyi from Shandong Yanding Holding Group was recognized for their breakthrough achievements in tumor early screening, successfully selected as a leading talent team in Qingdao [1][3] - The evaluation of leading talent teams focused on key areas such as new generation information technology, high-end equipment, and biomedicine, aiming to select core forces that can break through key technologies and promote industrial upgrades [3] Group 2 - Under the strategic layout of Chairman Liu Yuanzhu, Yanding Group has established a talent cultivation system that integrates both introduction and training [5] - The project team has formed a cross-disciplinary innovation consortium by integrating expertise in biomedical engineering, microfluidic technology, and multimodal medical big data [5] - The group has established collaborations with various universities and research institutions, creating multiple research platforms to enhance public health and clinical research capabilities [5] Group 3 - Professor Xiao Leyi has extensive experience in the field of genetics and microfluidic chips, having led four national-level research projects and published 48 papers [7] - The team focuses on the research and industrialization of liquid cell pathology biopsy technology, aiming to develop equipment and reagents with independent intellectual property rights and stable quality [7][8] - The project aims to enhance the early detection rate of tumors, reduce medical expenses for the public, and support the construction of a healthy China and high-quality urban economic development [8] Group 4 - Yanding Group plans to continue deepening its "talent-driven enterprise" strategy through a collaborative innovation model that integrates industry, academia, research, and medicine [10] - The goal is to create a comprehensive industrial chain ecosystem covering tumor early screening, precise diagnosis, and personalized treatment, injecting new technological momentum into the construction of a healthy China [10]